Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic… Read more
Market Cap & Net Worth: Vimian Group AB (publ) (VIMGF)
Vimian Group AB (publ) (PINK:VIMGF) has a market capitalization of $2.37 Billion ($2.37 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #8081 globally and #4149 in its home market, demonstrating a 28.57% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vimian Group AB (publ)'s stock price $4.50 by its total outstanding shares 525964772 (525.96 Million).
Vimian Group AB (publ) Market Cap History: 2022 to 2025
Vimian Group AB (publ)'s market capitalization history from 2022 to 2025. Data shows growth from $1.68 Billion to $2.37 Billion (8.55% CAGR).
Vimian Group AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vimian Group AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.57x
Vimian Group AB (publ)'s market cap is 5.57 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
75.62x
Vimian Group AB (publ)'s market cap is 75.62 times its annual earnings
359.02x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.68 Billion | $281.31 Million | -$7.20 Million | 5.98x | N/A |
| 2023 | $1.18 Billion | $331.73 Million | $9.84 Million | 3.57x | 120.27x |
| 2024 | $1.90 Billion | $374.80 Million | $18.50 Million | 5.08x | 102.92x |
| 2025 | $2.37 Billion | $425.00 Million | $31.30 Million | 5.57x | 75.62x |
Competitor Companies of VIMGF by Market Capitalization
Companies near Vimian Group AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Vimian Group AB (publ) by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Vimian Group AB (publ) Historical Marketcap From 2022 to 2025
Between 2022 and today, Vimian Group AB (publ)'s market cap moved from $1.68 Billion to $ 2.37 Billion, with a yearly change of 8.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.37 Billion | +24.31% |
| 2024 | $1.90 Billion | +60.89% |
| 2023 | $1.18 Billion | -29.69% |
| 2022 | $1.68 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Vimian Group AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.37 Billion USD |
| MoneyControl | $2.37 Billion USD |
| MarketWatch | $2.37 Billion USD |
| marketcap.company | $2.37 Billion USD |
| Reuters | $2.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.